CHENGDU, China, June 6, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating sacituzumab tirumotecan (sac-TMT) versus docetaxel in patients with previously...
Hence then, the article about the british medical journal publishes study results on sacituzumab tirumotecan for previously treated egfr mutant advanced nsclc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC )
Also on site :
- Witney Carson Claps Back at ‘DWTS’ Judge Carrie Ann Inaba, Joining Uproar Over Comments on Guillermo Rodriguez: ‘I Said What I Said’
- Disney Cruise Line Offers First Look Inside Disney Believe with New Frozen Dining, Encanto Show, and Themed Lounges
- Tom DeLonge Was in the Crowd When 43,000 Fans Serenaded Him With His Own Song: ‘He Was Definitely in His Feels’